Cargando…

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies

BACKGROUND: Adenosine inhibits the activation of most immune cells and platelets. Selective adenosine A2A receptor (A2AR) agonists such as regadenoson (RA) reduce inflammation in most tissues, including lungs injured by hypoxia, ischemia, transplantation, or sickle cell anemia, principally by suppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabin, Joseph, Zhao, Yunge, Mostafa, Ezzat, Al-Suqi, Manal, Fleischmann, Emily, Conaway, Mark R., Mann, Barbara J., Chhabra, Preeti, Brayman, Kenneth L., Krupnick, Alexander, Linden, Joel, Lau, Christine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420352/ https://www.ncbi.nlm.nih.gov/pubmed/37566593 http://dx.doi.org/10.1371/journal.pone.0288920

Ejemplares similares

Current Status of Immunomodulatory and Cellular Therapies in Preclinical and Clinical Islet Transplantation
por: Chhabra, Preeti, et al.
Publicado: (2011)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist()
por: Mann, Barbara J., et al.
Publicado: (2023)

Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
por: Reyes, Eliana, et al.
Publicado: (2019)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson
por: Bitar, Abbas, et al.
Publicado: (2015)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
por: Elkholy, Karim O, et al.
Publicado: (2021)

Hemodynamic and Respiratory Effects of Regadenoson During Radiologic Imaging in Infants and Children
por: Schloss, Brian, et al.
Publicado: (2021)

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Feasibility of detecting myocardial ischemia using first-pass contrast MRI and regadenoson
por: Lyons, Matthew, et al.
Publicado: (2012)

Regadenoson blood flow in type 1 diabetes (RABIT(1)D Study)
por: Groves, Daniel W, et al.
Publicado: (2014)

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge
por: Golzar, Yasmeen, et al.
Publicado: (2014)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Regadenoson Cardiac Stress Test-Induced Takotsubo Cardiomyopathy: A Case Report
por: Farid, Saira, et al.
Publicado: (2020)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
por: Abudiab, Muaz M., et al.
Publicado: (2014)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Inferior Myocardial Infarction Secondary to Coronary Artery Vasospasm Following Regadenoson Stress Imaging
por: Fogelson, Benjamin, et al.
Publicado: (2022)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification
por: Koenders, S. S., et al.
Publicado: (2019)

The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study
por: DiBella, Edward V. R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1dcjqo969j1lmd2b7p4f8rtods